Pharmacologic aspects of intrinsic sympathomimetic activity in beta-blocking drugs
- 1 May 1987
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (13) , F13-F17
- https://doi.org/10.1016/0002-9149(87)90035-x
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Antihypertensive Treatment and Serum LipoproteinsJournal Of Hypertension, 1985
- Coronary Insufficiency and β-BlockadeJournal of Cardiovascular Pharmacology, 1985
- ??- and ??-Adrenergic Receptor Subtypes Properties, Distribution and RegulationDrugs, 1984
- A Comparative Study Between 100mg Atenolol and 20mg Pindolol Slow-Release in Essential HypertensionDrugs, 1983
- Treatment of angina pectoris with pindolol: The significance of intrinsic sympathomimetic activity of beta blockersAmerican Heart Journal, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Periphere arterielle Verschlußkrankheit: keine absolute Kontraindikation von Beta-Rezeptorenblockern *Deutsche Medizinische Wochenschrift (1946), 1981
- Hemodynamic Effect of Pindolol in Essential Hypertension with Special Reference to the Resistance and Capacitance Vessels of the ForearmActa Medica Scandinavica, 1976
- Propranolol in the therapy of angina pectorisThe American Journal of Cardiology, 1966
- THE EFFECTS OF SYMPATHECTOMY ON THE ELECTROCARDIOGRAM AND EFFORT TOLERANCE IN ANGINA PECTORISHeart, 1964